After 66 child deaths, a clean chit, and a ‘vanishing act’: Maiden Pharma is coming back, rebranded
This is the second part of an investigative series examining pharmaceutical companies linked to the deaths of children from contaminated medicines, and the regulatory failures that allowed them to keep operating. It is supported by the Thakur Foundation. The foundation has not exercised any editorial control over the project.
Newslaundry ·